These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors. Garcia-Lavandeira M; Saez C; Diaz-Rodriguez E; Perez-Romero S; Senra A; Dieguez C; Japon MA; Alvarez CV J Clin Endocrinol Metab; 2012 Jan; 97(1):E80-7. PubMed ID: 22031517 [TBL] [Abstract][Full Text] [Related]
7. Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma. Gonzalez-Meljem JM; Haston S; Carreno G; Apps JR; Pozzi S; Stache C; Kaushal G; Virasami A; Panousopoulos L; Mousavy-Gharavy SN; Guerrero A; Rashid M; Jani N; Goding CR; Jacques TS; Adams DJ; Gil J; Andoniadou CL; Martinez-Barbera JP Nat Commun; 2017 Nov; 8(1):1819. PubMed ID: 29180744 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Andoniadou CL; Gaston-Massuet C; Reddy R; Schneider RP; Blasco MA; Le Tissier P; Jacques TS; Pevny LH; Dattani MT; Martinez-Barbera JP Acta Neuropathol; 2012 Aug; 124(2):259-71. PubMed ID: 22349813 [TBL] [Abstract][Full Text] [Related]
9. BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma. Larkin SJ; Preda V; Karavitaki N; Grossman A; Ansorge O Acta Neuropathol; 2014; 127(6):927-9. PubMed ID: 24715106 [No Abstract] [Full Text] [Related]
10. Pathology and pathogenesis of craniopharyngiomas. Larkin SJ; Ansorge O Pituitary; 2013 Mar; 16(1):9-17. PubMed ID: 22886701 [TBL] [Abstract][Full Text] [Related]
11. CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas. Campanini ML; Colli LM; Paixao BM; Cabral TP; Amaral FC; Machado HR; Neder LS; Saggioro F; Moreira AC; Antonini SR; de Castro M Horm Cancer; 2010 Aug; 1(4):187-96. PubMed ID: 21761366 [TBL] [Abstract][Full Text] [Related]
12. Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis. Gueorguiev M; Grossman AB Pituitary; 2009; 12(3):245-55. PubMed ID: 18946739 [TBL] [Abstract][Full Text] [Related]
13. Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases. Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Suri V; Sarkar C; Jagdevan A; Sharma BS; Sharma MC J Neurooncol; 2017 Jul; 133(3):487-495. PubMed ID: 28500561 [TBL] [Abstract][Full Text] [Related]
14. Stem cells and their role in pituitary tumorigenesis. Carreno G; Gonzalez-Meljem JM; Haston S; Martinez-Barbera JP Mol Cell Endocrinol; 2017 Apr; 445():27-34. PubMed ID: 27720895 [TBL] [Abstract][Full Text] [Related]